SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Wedbush Maintains Outperform on SpringWorks Therapeutics, Raises Price Target to $48

Wedbush maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Outperform and raises the price target from $45 to $48.

Benzinga · 05/13/2020 14:45

Wedbush maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Outperform and raises the price target from $45 to $48.